Singapore markets close in 1 hour 5 minutes

Guangdong Marubi Biotechnology Co., Ltd. (603983.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
32.12-0.09 (-0.28%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 12.92B
Enterprise value 11.31B
Trailing P/E 44.12
Forward P/E 46.08
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.34
Price/book (mrq)3.74
Enterprise value/revenue 4.69
Enterprise value/EBITDA 31.72

Trading information

Stock price history

Beta (5Y monthly) 0.14
52-week change 3-13.69%
S&P500 52-week change 328.04%
52-week high 337.93
52-week low 322.96
50-day moving average 329.87
200-day moving average 327.70

Share statistics

Avg vol (3-month) 32.3M
Avg vol (10-day) 32.43M
Shares outstanding 5401M
Implied shares outstanding 6407.03M
Float 872.35M
% held by insiders 180.82%
% held by institutions 17.72%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.25
Forward annual dividend yield 40.78%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 434.25%
Dividend date 3N/A
Ex-dividend date 419 Jul 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.09%
Operating margin (ttm)18.41%

Management effectiveness

Return on assets (ttm)3.07%
Return on equity (ttm)9.02%

Income statement

Revenue (ttm)2.41B
Revenue per share (ttm)6.03
Quarterly revenue growth (yoy)38.70%
Gross profit (ttm)N/A
EBITDA 223.18M
Net income avi to common (ttm)291.38M
Diluted EPS (ttm)0.73
Quarterly earnings growth (yoy)40.60%

Balance sheet

Total cash (mrq)1.76B
Total cash per share (mrq)4.39
Total debt (mrq)153.66M
Total debt/equity (mrq)4.35%
Current ratio (mrq)3.03
Book value per share (mrq)8.62

Cash flow statement

Operating cash flow (ttm)373.81M
Levered free cash flow (ttm)25.99M